By Jenifer Goodwin
HealthDay Reporter
MONDAY, May 21 (HealthDay News) — The food additive maltodextrin, commonly used in some artificial sweeteners, may worsen Crohn’s disease by encouraging the growth of E. coli bacteria in the small intestine, a new study suggests.
However, researchers stressed that the findings are preliminary and the tests were conducted in the lab, not in people, so it’s too soon to advise those with the inflammatory bowel disease to avoid maltodextrin.
FRIDAY, Sept. 9 (HealthDay News) — Good hygiene has saved millions of lives, protecting people from countless bacterial and viral infections, according to the U.S. Centers for Disease Control and Prevention.
But there is growing concern that strict adherence to good hygiene, though a valuable means of protecting health, has left humans open to other forms of illness.
TUESDAY, Feb. 22 (HealthDay News) — People with inflammatory bowel disease have double the risk of developing a potentially deadly blood clot (venous thromboembolism) in the legs or lungs as do people in the general public, a new study finds.
Inflammatory bowel disease includes Crohn’s disease and ulcerative colitis, both of which can cause abdominal pain, vomiting, diarrhea, weight loss and other problems.
THURSDAY, Jan. 27 (HealthDay News) — Celiac disease and Crohn’s disease share several genetic risk factors, a new study finds.
Celiac disease, which makes it hard to absorb nutrients properly, is an inherited autoimmune disease in which the lining of the small intestine is damaged by gluten and other protein found in wheat and some other grains. Crohn’s disease is a form of inflammatory bowel disease.
WEDNESDAY, Dec. 1 (HealthDay News) — Crohn’s disease may cause post-traumatic stress disorder (PTSD), a new study contends.
The study included nearly 600 Swiss adults with Crohn’s disease, an incurable inflammatory bowel disorder that causes severe pain and diarrhea.
FRIDAY, Sept. 3 (HealthDay News) — The risk of bowel surgery for children with Crohn’s disease is much lower than reported in previous studies, according to new findings.
Crohn’s disease involves chronic inflammation of the gastrointestinal tract. The exact cause is not known, but the condition is often associated with an immune response problem. Some recent studies have found that the risk of bowel surgery is as high as 34 percent one year after diagnosis and as high as 47 percent five years after diagnosis.
THURSDAY, June 24 (HealthDay News) — Mice with a gene variant linked to Crohn’s disease only develop the inflammatory bowel disorder if they are infected by a common norovirus called MNV, finds a new study.
Noroviruses are a group of viruses that cause gastroenteritis, an inflammation of the stomach lining.
WEDNESDAY, April 14 (HealthDay News) — Combination therapy with two drugs that control an unruly immune system provided the best relief yet seen for Crohn’s disease, a condition in which the body mistakenly attacks its own intestinal tissue.
The new finding promises to change current treatment of Crohn’s disease, said study leader Dr. William J. Sandborn, vice chair of gastroenterology and hepatology at the Mayo Clinic in Rochester, Minn.
The results were reported in the April 15 issue of the New England Journal of Medicine. Read More
THURSDAY, March 4 (HealthDay News) — Intestinal bacteria may contribute to obesity and metabolic syndrome, a new study in mice suggests.
“It has been assumed that the obesity epidemic in the developed world is driven by an increasingly sedentary lifestyle and the abundance of low-cost, high-calorie foods. However, our results suggest that excess caloric consumption is not only a result of undisciplined eating but that intestinal bacteria contribute to changes in appetite and metabolism,” senior study author Andrew Gewirtz, an associate professor of pathology and laboratory medicine at Emory University School of Medicine, said in a university news release. Read More
TUESDAY, Feb. 9 (HealthDay News) — People with active inflammatory bowel disease are much more likely to develop blood clots than people without the condition, a new study suggests.
And that may make preventive drug treatment necessary, it adds.
The study, done in the United Kingdom, compared data on 13,756 people who had inflammatory bowel disease (IBD) with 71,672 people who did not have it. None of the people were hospitalized. Between November 1987 and July 2001, 304 people developed a blood clot (venous thromboembolism). Read More
| Text Size: |  |
|
